HCG for Men: What It Does, Who It's For, and How to Get It (2026)

Executive Summary

When men start testosterone replacement therapy, the body stops producing LH and FSH — the hormones that tell the testes to make testosterone and support sperm production. The result: testicular atrophy, reduced sperm count, and often infertility. HCG (human chorionic gonadotropin) exists specifically to prevent this. It's a peptide hormone that binds to LH receptors in the testes, mimicking the signal that LH normally delivers. On TRT, HCG keeps the testes active and producing — maintaining testicular volume, preserving sperm production, and supporting intratesticular testosterone levels that exogenous testosterone alone can't provide.

HCG is one of the most important tools in the advanced TRT toolkit, yet many men start testosterone without understanding it exists — or have it dismissed by providers who don't specialize in hormone optimization. This guide covers exactly what HCG does in men, who should use it, the different protocols it's used in, what dosing looks like, costs in 2026, and how to access it. For context on TRT with HCG specifically, see our dedicated TRT with HCG guide. For the broader fertility-vs-TRT decision, see our TRT and fertility overview.

At-a-Glance Comparison

HCG use cases in men's hormone optimization as of 2026. Outcomes depend on individual HPT axis function, HCG dose, and duration of use.

What HCG Is and How It Works in Men

HCG is not a testosterone — it's the hormone that tells the testes to make testosterone. Understanding this distinction explains why it plays a completely different role from TRT. Buyers searching for hcg for men usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

HCG (human chorionic gonadotropin) is a glycoprotein hormone produced naturally during pregnancy — it maintains the corpus luteum's progesterone production during early gestation. In men, it's used for a completely different purpose: HCG binds to LH receptors on testicular Leydig cells with essentially the same affinity as LH, making it a functional LH analog. LH's job in men is to signal Leydig cells to produce testosterone. When exogenous testosterone is introduced through TRT, the hypothalamus detects high circulating testosterone levels and suppresses GnRH → LH → FSH release through negative feedback. The testes receive no LH signal and shut down production. Intratesticular testosterone (ITT) — the testosterone produced inside the testes themselves — drops dramatically. ITT is required for spermatogenesis, and it can be 50–100x higher inside the testes than in circulation when the axis is intact. Exogenous TRT raises serum testosterone, but does nothing to replace ITT. HCG bridges this gap: it delivers an LH-like signal directly to the Leydig cells even when natural LH secretion is suppressed. The testes remain active, ITT is maintained, and spermatogenesis continues. This is why HCG is the primary tool for fertility preservation on TRT. Beyond fertility, maintaining Leydig cell activity also preserves testicular volume — a cosmetic and functional concern many men on TRT report but isn't addressed by testosterone alone. Some men also report that HCG improves subjective wellbeing on TRT — mood, libido, and energy — potentially because of the maintained local testosterone environment or HCG's effects on other testicular cell types (Sertoli cells produce estradiol and other factors). See our TRT and HCG overview for how HCG fits within a complete TRT protocol. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: confusing HCG with testosterone — HCG is a signal molecule that stimulates testosterone production, not a hormone replacement. It works by activating your testes' own testosterone synthesis, not by adding exogenous testosterone. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

HCG on TRT: Protocols, Dosing, and Timing

How you add HCG to a TRT protocol determines how well it works — dosing, injection frequency, and timing all matter for optimal results. Buyers searching for hcg for men usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

HCG is typically administered via subcutaneous injection, similar to insulin injections — small, simple, and manageable for at-home use. It comes in powder form that must be reconstituted with bacteriostatic water, then stored refrigerated. Standard dosing for TRT add-on use ranges from 250–500 IU injected 2–3x per week, typically on non-TRT injection days to smooth out the hormonal stimulus. Some protocols use 500 IU 2x/week; others use lower doses (250 IU) more frequently (3x/week). The goal is continuous testicular stimulation — avoiding the high peaks and low troughs that come from infrequent high-dose HCG. High-dose, infrequent HCG (1000+ IU 2x/week or more) can actually desensitize LH receptors over time, reducing its own effectiveness — a phenomenon known as LH receptor downregulation. This is why physiologic lower doses injected more frequently are preferred in most modern TRT+HCG protocols. Protocol structure for TRT + HCG: TRT injection day example — Monday: testosterone injection; Wednesday: HCG injection; Friday: testosterone injection; Sunday: HCG injection. The HCG off-TRT-day pattern keeps stimulus continuous. Some physicians simplify this to 3x weekly HCG at low dose (250 IU) regardless of TRT timing. HCG's half-life is approximately 36 hours — longer than LH (minutes), which is why 2–3x weekly injections are sufficient where natural LH pulses occur many times per day. Estradiol monitoring is important on HCG: HCG stimulates aromatase activity in the testes, increasing estradiol production. Men with already-elevated estradiol on TRT may see further increases with HCG. Regular estradiol checks and low-dose anastrozole management (if needed) are standard practice. See our anastrozole on TRT guide for estrogen management. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: high-dose infrequent HCG dosing (1000+ IU 2x/week) causing LH receptor desensitization over time — lower doses injected more frequently maintain receptor sensitivity better than high-dose less-frequent protocols. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

HCG Monotherapy: An Alternative to TRT

For men with secondary hypogonadism who want to raise testosterone without shutting down their natural axis, HCG monotherapy is a legitimate first-line option that most providers don't discuss. Buyers searching for hcg for men usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

In secondary hypogonadism — where the testes are functional but aren't receiving adequate LH signal from the hypothalamic-pituitary axis — HCG monotherapy can raise testosterone without introducing exogenous testosterone. By directly stimulating Leydig cells, HCG drives the testes to produce more testosterone endogenously. The HPT axis is bypassed at the LH level but the testicular machinery is activated, so spermatogenesis continues and the natural testosterone production process is maintained. HCG monotherapy typically produces testosterone increases of 200–500 ng/dL from baseline in secondary hypogonadism cases, depending on testicular responsiveness and dosing. Men with low testosterone in the 200–350 ng/dL range due to secondary hypogonadism can often reach mid-normal range (450–700 ng/dL) with HCG alone. Standard monotherapy dosing: 500–1000 IU subcutaneous injection 3x per week. Some protocols use 1500–2000 IU 2x/week, though this risks receptor desensitization. Response is confirmed via labs at 4–6 weeks. Who is the right candidate for HCG monotherapy? Men with: confirmed secondary hypogonadism (low T + low-normal LH/FSH); intact testicular function (testes can respond to LH stimulation); active fertility goals or desire to maintain natural production; preference for endogenous testosterone over exogenous hormone replacement. Important caveat: HCG monotherapy does not suppress FSH. In fact, FSH may rise modestly from the secondary GnRH feedback effects, or remain low if the primary deficit is at the hypothalamic-pituitary level. For men whose main fertility concern is FSH and spermatogenesis, adding low-dose FSH analogs (like follitropin alfa) can be done alongside HCG — this is a more advanced protocol typically managed by reproductive endocrinologists. How does HCG monotherapy compare to enclomiphene? Both target secondary hypogonadism with fertility preservation. Enclomiphene works upstream (at the hypothalamus/pituitary) raising both LH and FSH; HCG works downstream (at the testes) delivering the LH signal directly. Enclomiphene tends to produce a stronger FSH rise, which may be better for spermatogenesis specifically. HCG produces more reliable and direct testicular stimulation. Some men use both. See our enclomiphene for fertility guide for the full comparison. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: expecting HCG monotherapy to work for primary hypogonadism — if the testes are damaged or non-functional (high LH/FSH with low T), adding more LH-like stimulus via HCG won't produce meaningful testosterone. Diagnosis first. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

HCG for Fertility: Timing, Sperm Recovery, and Active Conception

HCG is one of the primary tools in male fertility medicine — understanding how and when to use it around conception attempts matters for outcomes. Buyers searching for hcg for men usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

For men actively trying to conceive while on TRT, HCG is typically the first intervention recommended before discontinuing testosterone entirely. Adding HCG to an existing TRT protocol usually restores meaningful sperm production within 60–90 days — the time required for a full spermatogenic cycle. In men who were on TRT without HCG and developed oligospermia or azoospermia, HCG can recover sperm parameters in most cases given sufficient time — though recovery is not guaranteed and timeline varies significantly by how long TRT suppressed the axis and individual HPT resilience. For IUI and IVF cycles: sperm quality matters. Adding HCG to TRT 60–90 days before planned egg retrieval gives adequate lead time for sperm recovery. Reproductive endocrinologists often recommend combining HCG with FSH analogs (like follitropin alfa) for men with severe oligospermia — FSH directly supports Sertoli cell function and spermatogenesis in ways HCG alone doesn't. For men who have been on TRT for years without HCG and now face fertility challenges, a baseline semen analysis is essential to understand where sperm parameters are. If azoospermia (zero sperm) is present, more aggressive interventions may be needed: testicular sperm extraction (TESE) or extended HCG + FSH treatment under reproductive endocrinology oversight. Off-cycle HCG for fertility preservation: a minority of men who want to preserve maximum fertility opt for intermittent TRT — cycling off testosterone and using HCG to maintain testicular function during breaks. This is less common but used in younger men who want the benefits of TRT during active phases while protecting long-term fertility. Coordination between a men's health provider and reproductive endocrinologist is strongly recommended when active conception is the goal. See our TRT and fertility guide for the complete fertility-preservation decision tree. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: assuming sperm recovery is rapid after adding HCG to suppressive TRT — sperm take 60–90 days to develop (one spermatogenic cycle), so plan lead time before fertility treatment cycles and confirm baseline semen analysis before assuming HCG has worked. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

HCG for Testicular Atrophy: Prevention and Reversal

Testicular atrophy is one of the most common complaints from men on TRT — and one of the most preventable with appropriate HCG use. Buyers searching for hcg for men usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Testicular atrophy on TRT is predictable and almost universal when HCG is not included. Without LH stimulation, Leydig cells become quiescent, fluid dynamics within the testes change, and overall testicular volume decreases — often noticeably within 3–6 months of starting TRT. HCG prevents this by keeping Leydig cells active. When started alongside TRT from day one, testicular volume is typically preserved at pre-TRT baseline. When added later after atrophy has already occurred, HCG can produce partial recovery — some volume returns as Leydig cells reactivate, but full reversal to pre-TRT volume is not guaranteed, particularly after prolonged atrophy. The degree of atrophy reversal depends on: duration of atrophy before HCG was added; individual testicular sensitivity to LH/HCG stimulation; and HCG dose adequacy. Most men who add HCG after atrophy describe meaningful improvement in 2–4 months, though the process is gradual. Beyond cosmetics, testicular atrophy matters functionally — it's a marker of reduced testicular activity, including reduced intratesticular testosterone and reduced Sertoli cell function. Some men on TRT without HCG report that subjective wellbeing improves after adding HCG, with improvements in libido, mood, and energy — potentially tied to the return of normal testicular function and the hormonal environment it maintains. If you started TRT without HCG and are now experiencing atrophy, adding HCG is the appropriate first step — it's rarely too late to see some benefit. The earlier HCG is started, the better the outcome for volume maintenance. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: waiting until significant atrophy has developed before adding HCG — prevention is far more effective than reversal. Starting HCG with TRT from day one is the best practice for testicular preservation. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

HCG for TRT Restart and Coming Off Testosterone

Men who want to discontinue TRT face a recovery challenge — the natural HPT axis needs time to restart. HCG accelerates this process. Buyers searching for hcg for men usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Men who stop TRT cold turkey often face a challenging recovery period: the hypothalamic-pituitary axis takes weeks to months to restore natural LH/FSH signaling, during which testosterone remains low and symptoms are significant. HCG is used as a bridge during this recovery period. By stimulating Leydig cells directly, HCG maintains testosterone production from the testes while the natural LH/FSH system re-establishes itself. A typical TRT restart protocol: taper TRT, introduce HCG at 500–1000 IU 3x/week to maintain testicular function and testosterone during the axis recovery period; after 4–8 weeks, begin tapering HCG while monitoring LH/FSH recovery; once natural LH/FSH are rising and testosterone is maintained naturally, HCG can be discontinued. Some restart protocols add SERMs (clomiphene or enclomiphene) after the HCG phase to further stimulate the hypothalamic-pituitary axis from above. The combination of HCG (testicular stimulation) + SERM (hypothalamic-pituitary stimulation) produces faster, more complete axis recovery than either alone. Who needs a TRT restart protocol? Men who used TRT and want to: father children and transition off exogenous testosterone; restore natural testosterone production; reassess whether they still need TRT after lifestyle changes; or see if TRT suppression was reversible. Recovery completeness depends heavily on: how long TRT was used (longer = slower recovery), individual HPT axis resilience, age at discontinuation, and whether testicular function was maintained during TRT (with or without HCG). See our complete TRT guide for context on long-term TRT considerations. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: stopping TRT abruptly without HCG bridge support — cold-turkey TRT cessation results in extended low-testosterone periods while the axis recovers, causing significant symptomatic regression that HCG largely prevents. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

HCG Costs in 2026 and How to Get It

HCG is available through telehealth providers with a prescription — here's what it costs and what to look for in a provider. Buyers searching for hcg for men usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

HCG in the US is a prescription medication available through licensed pharmacies in injectable form. In 2026, pharmaceutical-grade HCG is primarily available through compounding pharmacies — the branded products (Pregnyl, Novarel) are available but expensive at retail. Compounded HCG via telehealth with a men's health provider runs $60–$150/month for the medication itself, depending on dose and pharmacy. Some men use it at lower doses (250–500 IU 2–3x/week), which means a 10,000 IU vial lasts several weeks. Total cost of TRT + HCG protocol: typically $150–$350/month through telehealth, including provider fees, lab monitoring, testosterone, and HCG. This varies by platform tier. Accessing HCG: the clearest path is through a men's health telehealth provider who offers full TRT + HCG protocols. Not all TRT telehealth platforms include HCG — many budget providers offer testosterone-only and either don't mention HCG or charge extra. When evaluating a provider, ask directly: Do you offer TRT protocols that include HCG? Is HCG bundled or an additional cost? What dose and injection frequency do you use? Do you monitor estradiol when HCG is added? For HCG monotherapy (without TRT): not all telehealth providers are set up for this — Defy Medical and Marek Health are among the platforms with experience prescribing HCG monotherapy for secondary hypogonadism. Budget platforms focused on testosterone-only are unlikely to offer this. See our best online TRT clinics 2026 and our provider comparison tool for options that include HCG protocols. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: sourcing HCG from gray-market peptide suppliers — pharmaceutical-grade HCG is a sterile injectable; unverified compounding sources lack the sterility assurance and dosage accuracy of licensed compounding pharmacies. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

HCG protocols require a prescribing physician who understands how to combine it with TRT or use it as monotherapy — not all telehealth providers offer or understand HCG. The providers below have experience with full TRT + HCG protocols, including lab-based monitoring, estradiol management, and fertility-preserving protocol design.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

What does HCG do for men on TRT?

HCG acts as an LH analog — it stimulates the Leydig cells in the testes to maintain testosterone production and spermatogenesis even when exogenous testosterone from TRT suppresses natural LH secretion. The primary benefits are: preserved fertility (maintaining sperm production via intratesticular testosterone), prevention of testicular atrophy, and subjective wellbeing improvements that some men report when testicular function is maintained.

Does HCG increase testosterone in men?

Yes — HCG stimulates Leydig cells to produce testosterone. On TRT, it raises intratesticular testosterone (which TRT alone doesn't restore) rather than serum testosterone, which is already elevated by the exogenous testosterone. In HCG monotherapy (without TRT), serum testosterone rises directly as the testes produce more endogenous testosterone in response to HCG's LH-mimicking stimulus.

Can HCG restore fertility after TRT?

Yes, in most cases — though timeline and completeness depend on duration of TRT use and individual HPT axis resilience. Adding HCG to TRT typically restores meaningful sperm production within 60–90 days (one spermatogenic cycle). For men who used TRT for years without HCG and developed azoospermia, recovery may take longer and may require additional FSH analog therapy or reproductive endocrinology guidance.

What is the standard HCG dose for men on TRT?

Most protocols use 250–500 IU subcutaneous injection 2–3 times per week, on non-TRT injection days. This provides continuous testicular stimulation while avoiding the LH receptor desensitization that can occur with high-dose infrequent HCG. Higher doses (500–1000 IU 3x/week) are used for HCG monotherapy or when trying to actively recover sperm production.

Does HCG prevent testicular atrophy?

Yes — HCG is the primary intervention for preventing TRT-induced testicular atrophy. By keeping Leydig cells active through continuous LH receptor stimulation, testicular volume is maintained at or near pre-TRT baseline. HCG is far more effective at prevention than reversal — starting it with TRT from day one is the best practice. HCG can partially reverse atrophy that has already occurred, but full reversal after prolonged atrophy is not guaranteed.

Can I use HCG instead of TRT?

For secondary hypogonadism — yes. HCG monotherapy can raise testosterone by stimulating endogenous production through Leydig cells, without introducing exogenous testosterone. This preserves the natural HPT axis and maintains fertility. Typical response: testosterone rises by 200–500 ng/dL from baseline with 500–1000 IU HCG 3x/week. It's most appropriate for men with secondary hypogonadism (low T + low-normal LH/FSH) who want to avoid exogenous testosterone.

Does HCG raise estrogen in men?

Yes — HCG stimulates testicular aromatase activity, increasing local estradiol production. Men already managing estradiol on TRT may see further estradiol increases when HCG is added. Regular estradiol monitoring and low-dose aromatase inhibitor management (anastrozole) is standard practice for men on TRT + HCG who develop elevated estradiol. This is manageable with proper monitoring — not a reason to avoid HCG.

How long does HCG take to work?

Intratesticular testosterone rises quickly — within days to a week of starting HCG as Leydig cells begin responding. Sperm production improvements take 60–90 days (one full spermatogenic cycle). Testicular volume recovery from atrophy is gradual — 2–4 months of consistent HCG use is typically needed to see meaningful volumetric improvement. Subjective wellbeing changes some men report (libido, mood, energy) often appear within the first 2–4 weeks.

Is HCG legal and available in the US?

Yes — HCG is a FDA-approved prescription medication available through licensed pharmacies. In practice, most men access it through compounding pharmacies via telehealth providers, as pharmaceutical-grade compounded HCG is more affordable than branded alternatives. Gray-market HCG from peptide suppliers is not recommended — injectable medications require pharmaceutical-grade sterility that unverified sources cannot guarantee.

How much does HCG cost for men?

Compounded HCG through telehealth costs approximately $60–$150/month for the medication, depending on dose and pharmacy. A complete TRT + HCG protocol (including provider fees, testosterone, and HCG) typically runs $150–$350/month at quality telehealth providers. HCG is generally not dramatically more expensive than testosterone alone when accessed through an optimized telehealth protocol.